BioNTech SE American Depositary Share (BNTXN)
BMV
Closed
Oct 5, 2026
Day's Range
1,645.0052 wk Range
1,456.73Overview - BNTXN - BioNTech SE American Depositary Share
Key Statistics
Valuation
Enterprise Value
8.23T
P/E (Trailing)
‪1.65‬
PEG Ratio
‪0.01‬
Price / Sales (TTM)
‪155.99‬
Price / Book
‪1.12‬
EV / EBITDA
‪-289.85‬
Profitability
Gross Margin
‪8.14%‬
Profit Margin
‪-63.63%‬
Operating Margin
‪-806.62%‬
Return on Assets
‪-5.41%‬
Return on Equity
‪-9.30%‬
Ownership
Shares Outstanding
251.20M
Float
109.06M
Held by Insiders
‪57.28%‬
Held by Institutions
‪20.47%‬
Price stats
Beta
‪1.29‬
50-Day Avg
‪1,702.80‬
200-Day Avg
‪1,692.93‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BNTXN - BioNTech SE American Depositary Share
Peers - BNTXN - BioNTech SE American Depositary Share
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
Profile Summary - BNTXN - BioNTech SE American Depositary Share
About
BioNTech SE American Depositary Share is the U.S.-traded depositary share of BioNTech SE, a Germany-based biotechnology company focused on immunotherapy and vaccines. The company develops cancer therapeutics, including individualized treatment approaches such as personalized immunotherapies, and also works on vaccines…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
